Transdermal drug delivery has gained a solid market position in a few specialty markets, owing to the unique advantages it provides in selected therapeutic applications. Now these advantages are beginning to inure to a class of conditions that are particularly well-suited to the major benefits of transdermal drug administration.

Applied Data Research Analyzes the Market and Competitive Factors Driving the Growth of Transdermal Prescription Pain Patches and Gels

Greystone Associates Analyzes Therapeutic Sectors and Growth Prospects

Greystone Associates Analyzes the Impact of Generics, Post-launch Complications, and New Transdermal Products on Demand and Revenue.

As patients live longer and are diagnosed with chronic and often debilitating ailments, caregivers and managed care organizations are bracing for a dramatic increase in self-administration of drug therapies in non-traditional settings for a number of conditions. Because non-compliance with prescription protocols is a major healthcare concern, particularly in older patients taking several prescribed drugs, transdermal patches continue to attract attention from both drug developers and drug packaging designers.